Healthcare & Pharmaceuticals

The algorithms that make social media addictive have become powerful mechanisms for drug dealers
Hospital Corporation of America (HCA) - the world's largest operator of private clinics and hospitals - has come under the spotlight for performing unnecessary cardiac procedures, notably in Florida.
A Congressional investigation of the money that drug companies give as supposed educational grants has found that the payments are growing rapidly and are sometimes steered by marketing executives to doctors and groups who push unapproved uses of drugs.
Over the last two years, thousands of people have gathered to counter the annual conventions of the biotechnology industry in Boston and San Diego. This year, people will be converging on Toronto to broaden the biojustice movement and challenge the biotechnology industry and their vision for our future. It will be a gathering to learn, strategize and network about genetic engineering in agriculture and pharmaceuticals, biowarfare, genetic and non-genetic discrimination, trade regimes and corporate control, patenting of life and more. This event is timed to challenge the industry's annual convention BIO2002, Toronto, June 9-12.
Which are the world's worst multinationals? Which are the best?
Three major U.S. medical associations - the American Academy of Family Physicians, the American Academy of Pediatrics and the American College of Cardiology - have bowed to pressure from activist doctors to stop accepting corporate donations from Coca-Cola. The campaigners say Coke exerted undue influence over the medical groups.
Myriad Genetics has lost its right to be the exclusive U.S. commercial provider of genetic screening tests for breast cancer or ovarian cancer. The American Civil Liberties Union (ACLU), which sued the company, claimed that the patent would limit scientific research as well as health care options for women.
GlaxoSmithKline is to discount significantly its pneumonia vaccine for private customers in Africa after claims from a medical charity it is "profiteering" by charging western prices.
US officials have refused to bust Bayer's monopoly on anthrax drugs, even though generic drugs would save $millions. Bayer's patent was protected under the WTO. Now those rights are challenged.